Status:
COMPLETED
Effect of Acupoint Stimulation on Lactate During Cerebral Endovascular Intervention
Lead Sponsor:
Air Force Military Medical University, China
Conditions:
Endovascular Procedures
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
It is advocated that neuroprotection should be increased before endovascular treatment and that the penumbra should be protected from reperfusion damage after recanalization. Monitoring lactate and pH...
Eligibility Criteria
Inclusion
- age ≥18 years
- scheduled for cerebral endovascular intervention
Exclusion
- American Society of Anesthesiologists status over level three
- history of cerebral vascular intervention
- history of severe neurological disease (stroke, neurological degenerative disease, psychiatric disease)
- severe hepatic or renal dysfunction
- severe glucose disorder or thyroid dysfunction
- contraindications to transcutaneous electrical stimulation (infection or injury of the skin area, implanted electrical devices)
Key Trial Info
Start Date :
October 30 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 30 2024
Estimated Enrollment :
28 Patients enrolled
Trial Details
Trial ID
NCT06521645
Start Date
October 30 2024
End Date
December 30 2024
Last Update
January 14 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
the First Affiliated Hospital of the Air Force Military Medical University
Xi'an, Shaanxi, China